New CDER Impact Story on How Computational Analysis of a 3D Mucociliary Model Can Help Predict Drug Uptake – Drug Information Update

If your email program has trouble displaying this email, view it as a web page.   How Computational Analysis of a 3D Mucociliary Clearance Model Can Help Predict Drug Uptake and Lead to More Generic Nasal Drug Products A mucociliary clearance model developed by CDER and its research partners can help to predict the effects of changes in the properties of nasally delivered drug candidates on drug exposures in patients. This capability can aid in the development of new safe and effective nasally inhaled drugs as well as generics of these complex products. Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA